Skip to main content
Clinical Trials/CTRI/2024/02/062289
CTRI/2024/02/062289
Not yet recruiting
Phase 4

A Comparative evaluation of Platelet Rich Fibrin Matrix (PRFM) AND Coronally Advanced Flap(CAF) with and without Peripheral Blood Mesenchymal Stem Cells (PBMSCs) in the surgical management of Gingival Recession Type 1 – A Split-mouth Randomised Controlled Trial.

DR JEEVIKA A DAS0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K060- Gingival recession
Sponsor
DR JEEVIKA A DAS
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
DR JEEVIKA A DAS

Eligibility Criteria

Inclusion Criteria

  • Systemically healthy male and female subjects in the age group of 20\-50 years, with gingival recession type 1 defect on at least 2 adjacent teeth, with no radiographic evidence of interdental bone loss.
  • Probing pocket depth \= 3 mm.
  • Adequate width of attached gingiva.

Exclusion Criteria

  • Pregnant/lactating women.
  • Patients on drug therapy known to affect the number and function of platelets in the past 3 months.
  • Patients with abnormal platelet count or having disease affecting platelet count.
  • Patients with immunologic diseases.
  • Current and former smokers.
  • Patients having a history of periodontal therapy in the last 6 months.
  • Any other contraindications for periodontal surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials